MBRX - 2.54 Pre-market now at 2.66/2.83 Moleculin Comments on Recent FDA Drug Approvals for Acute Myeloid Leukemia http://stockcharts.com/c-sc/sc?s=MBRX&p=D&b=5&g=0&i=t73267857424&r=1502280734415 http://stockcharts.com/c-sc/sc?s=MBRX&p=W&b=5&g=0&i=t34824500622&r=1502280756274